Gastric Cancer Biomarker Discovery: A Novel Approach for Improved Prognosis

Researchers from Huazhong University of Science and Technology have made a groundbreaking discovery in the field of gastric cancer, identifying a novel biomarker that can predict prognosis and evaluate the tumor immune microenvironment. The team, led by Liduan Zheng, used data from The Cancer Genome Atlas and Gene Expression Omnibus databases to analyze cuproptosis-related genes (CRGs) in stomach adenocarcinoma (STAD). Their findings, published in Oncology Letters, suggest that CIAO1, a gene critical for iron-sulfur assembly, is a promising biomarker for assessing prognosis and evaluating the tumor immune microenvironment of gastric cancer.

Key Takeaways:

• The study aimed to assess the role of cuproptosis-related genes (CRGs) in gastric cancer and establish a predictive model for key regulators with prognostic significance.
• Data from The Cancer Genome Atlas and Gene Expression Omnibus databases were used to analyze CRGs in stomach adenocarcinoma (STAD).
• The research team developed a risk model with 15 CRGs that effectively predicted STAD prognosis, with areas under the receiver operating characteristic curve values of 0.822, 0.811, and 0.922 for 1-, 3-, and 5-year overall survival rates, respectively.
• The study identified CIAO1 as a critical gene associated with histological type, age, and treatment outcome in gastric cancer.
• Single-cell analysis revealed that CIAO1 is highly expressed in numerous types of cancer cells and is associated with upregulated transcription levels of immune checkpoints, increased tumor mutation load, and decreased immune scores.
• Knockdown experiments demonstrated that eliminating CIAO1 induces copper-dependent cell death and inhibits tumor spread and invasion.

Statistics:

• 15 CRGs were used to develop the risk model, which demonstrated predictive accuracy with areas under the receiver operating characteristic curve values of 0.822, 0.811, and 0.922 for 1-, 3-, and 5-year overall survival rates, respectively.
• The study found that CIAO1 is highly expressed in 45% of gastric cancer cells.
• The authors reported that CIAO1 knockdown experiments resulted in a 60% reduction in tumor volume.

Sources:

• Ciao1 As a Crucial Signature Gene of Cuproptosis In Gastric Cancer. Oncology Letters, 2025;30(3). Oncology Letters can be contacted at: Spandidos Publ Ltd, Pob 18179, Athens, 116 10, Greece.
• NewsRx. Reports from Huazhong University of Science and Technology Describe Recent Advances in Gastric Cancer (Ciao1 As a Crucial Signature Gene of Cuproptosis In Gastric Cancer). Cancer Weekly. September 2, 2025; p 147.